Call us:

Ion-Mobility DIA (timsTOF) Guide: Ion Mobility, Window Design & DIA-NN Parameters

This resource serves teams evaluating Ion-Mobility DIA (aka diaPASEF) on timsTOF who want actionable settings more than theory.

What you'll get:

  • How ion mobility (IM) changes DIA design and why it boosts selectivity.
  • How to choose window schemes (m/z × IM) that balance coverage, precision, and duty cycle.
  • A DIA-NN parameter checklist for ion-mobility DIA data (library strategy, FDR, IM-aware alignment, MBR).
  • QC & release thresholds (FDR, CV, missingness, RT/IM residuals) and scenario-specific presets.
  • Service-grade deliverables and reproducibility practices (parameters.json, two-matrix policy for MBR).

What Ion-Mobility DIA Adds to a DIA Service Workflow

Ion-Mobility DIA couples DIA with Parallel Accumulation–Serial Fragmentation on timsTOF. Instead of acquiring only across m/z, ion-mobility DIA slices the space in m/z × 1/K0 (ion mobility). This reduces co-fragmentation, improves interference handling, and enables narrower effective windows without exploding cycle time—if the window plan is well designed.

Service positioning:

RAW → feature extraction in m/z × 1/K0 → (library-based / library-free) search & scoring → IM/RT alignment → FDR control → MBR (if justified) → protein inference → quant matrices → QC → handoff.

Window Design for Ion-Mobility DIA — Practical Optimization

Design windows in two dimensions: m/z bands and IM (1/K0) slices. Your goal is to meet cycle-time and sampling density requirements while keeping each window's chemical complexity manageable.

Ion-Mobility DIA window design schematic showing m/z × 1/K0 tiling with IM slices, variable m/z windows, and 8–12× peak sampling.

Inputs that constrain your plan

  • Gradient length & peak width: shorter gradients demand faster cycles (more frames per minute) to adequately sample peaks.
  • Sample complexity & load: plasma/FFPE need stricter decongestion (narrower windows or more IM slices).
  • Target depth & cohort size: deep coverage favors more, narrower windows; high throughput favors simpler schemes.

Choosing counts and widths (directional templates)

  • IM slices (per cycle): commonly 4–8 slices give a good balance of selectivity vs. duty cycle.
  • m/z windows per IM slice: typically 6–12 per slice for proteome-wide work.
  • Total windows per cycle: IM slices × m/z windows (e.g., 6 IM slices × 8 m/z windows = 48 total).
  • Window width: narrower at crowded m/z regions (e.g., 500–800 m/z) and/or at IM bands with higher peptide density; wider where density is low.
  • Cycle time target: aim to sample chromatographic peaks 8–12× over apex; sanity-check that total windows × accumulation/ramp per frame does not violate this.

Templates (indicative, tune in pilot):

  • 30 min gradient, moderate complexity: ~4–6 IM slices, 6–8 m/z windows per slice (≈24–48 total).
  • 60 min gradient, standard complexity: ~6–8 IM slices, 8–10 m/z windows per slice (≈48–80 total).
  • 120 min gradient, deep coverage: 8 IM slices, 10–12 m/z windows per slice (≈80–96 total).

Fixed vs. variable windows; when to use GPF

  • Variable (data-density–aware) windows outperform fixed width in crowded regions.
  • GPF (gas-phase fractionation) libraries: if you pursue maximum depth, schedule additional targeted windows to build a project library; otherwise pick predicted/library-free to accelerate cohorts.

Practical numbers by matrix/gradient (indicative)

Matrix Gradient IM slices m/z windows/slice Total tiles Notes
Cell/tissue 60 min 6–8 8–10 48–80 Good default for cohorts
Depleted plasma 60 min 8 8–10 64–80 Prefer narrower m/z where dense
FFPE 90–120 min 8 10–12 80–96 Depth with conservative MBR

Common traps (and fixes)

  • Over-tiling: too many ultra-narrow tiles → cycle time inflates → under-sampled peaks. Fix: reduce IM slices or widen m/z windows until sampling ≥8×/peak.
  • Uneven IM binning: one slice carries most features. Fix: re-bin 1/K0 to equalize density.
  • Copy-pasting schemes across matrices: plasma ≠ lysate. Fix: for plasma/FFPE, add IM slices or narrow m/z in dense bands; increase QC frequency.

DIA-NN for ion-mobility DIA — Parameter Checklist (IM-Aware)

Use this as a pilot-to-production checklist. Record every switch in parameters.json.

Library strategy

  • Library-free / predicted library for high-throughput cohorts and fast turnaround.
  • Project (DDA/GPF) library for deep-coverage programs. Keep peptide candidates bounded (length 7–30 aa, 2–4 charges, enzyme specificity, ≤2 missed cleavages) to avoid false discovery inflation.

Scoring & FDR

  • Set 1% peptide FDR and 1% protein FDR; disclose target–decoy method and q-value column in exports.
  • Limit variable modifications (e.g., Carbamidomethyl(C) fixed; Oxidation(M) and Acetyl(Protein N-term) variable) to restrain search space.

IM-aware alignment & tolerances

  • Enable IM (1/K0) in search/alignment; store IM residuals per run.
  • RT alignment anchored by QC-pool; report median RT residual and 95th percentile.
  • For IM residuals, define a project bound (e.g., ≤ a small fraction of your slice width) and track violations in QC.

Match-Between-Runs (MBR)

  • Default to conservative MBR; use stricter evidence thresholds in plasma/FFPE.
  • When MBR changes calls materially, deliver two matrices: MBR-off (primary) and MBR-on (sensitivity) for downstream robustness checks.

Cross-batch handling

  • Merge batches after alignment QC passes (RT & IM).
  • Normalize with a QC-anchored approach; keep a bridging QC every 10–12 injections.
  • Lock export templates and grouping policy (parsimonious).

Practical compute notes

  • Plan for 16–32 vCPU and 64–128 GB RAM per concurrent job (mid-tier baseline).
  • Use NVMe for intermediates. Cache feature/score tables so FDR/MBR tweaks don't trigger full re-runs.

QC & Release Criteria — Measurable Thresholds and Plots

Define thresholds before production; tune them on a 10–20-injection pilot per matrix/gradient.

Metric Release (Pass) Preferred Target What to plot
Peptide / Protein FDR 1% / 1% 0.5% / 1% FDR curves, score histograms
QC-pool protein CV (median) ≤ 20% ≤ 15% CV distribution per QC-pool
Sample-level missingness ≤ 30% ≤ 20% Missingness heatmap
RT alignment residual (median) ≤ 30 s ≤ 15 s RT residuals vs. run order
IM alignment residual (median) within preset bound as low as feasible IM residuals per run
MBR contribution (rows impacted) ≤ 20% ≤ 10% MBR off/on delta summary

Red/Yellow/Green gating:

  • Green: all pass; proceed.
  • Yellow: one marginal breach (e.g., CV ~22%); re-check normalization, continue with close monitoring.
  • Red: multiple breaches or major alignment failure; hold, re-extract/re-score, or retune windows.

Outlier policy: flag samples with >2.5× MAD on missingness, RT residuals, or total intensity. Investigate carryover, spray instability, or tile congestion.

Practical Ion-Mobility DIA Configurations for Key Research Scenarios

High-throughput cohorts (budget/time sensitive)

  • Windows: 4–6 IM slices × 6–8 m/z windows/slice (≈24–48 total).
  • Library: library-free / predicted.
  • DIA-NN: conservative MBR; QC-anchored RT/IM alignment.
  • KPI direction: CV ≤ 20%, missingness ≤ 30%, stable IDs across runs.
  • Why: shortest TAT with acceptable precision.

Deep-coverage discovery (ample material; depth prioritized)

  • Windows: 8 IM slices × 10–12 m/z windows/slice (≈80–96 total).
  • Libraryproject/GPF with curated filters.
  • DIA-NN: strict interference control, MBR only with strong evidence.
  • KPI direction: higher reproducible protein counts, lower missingness; compute cost ↑.
  • Why: maximize sensitivity while maintaining auditability.

Plasma / FFPE (hard matrices)

  • Windows: add IM slices or narrow m/z windows in dense regions.
  • Library: predicted or project; avoid oversized candidate spaces.
  • DIA-NN: raise MBR thresholds; increase QC frequency.
  • KPI direction: missingness controlled; false-positive risk minimized.
  • Why: chemistry-driven interference requires conservative design.

timsTOF ion-mobility DIA method migrations (cross-site or cross-batch)

  • Windows: keep scheme stable across sites; only minor retuning by density.
  • DIA-NN: lock versions; apply the same grouping/FDR policy.
  • Deliverable: include parameters.json and export template versions.
  • Why: portability and audit trails matter more than squeezing a few IDs.

Deliverables & Reproducibility (What You Receive)

  • Protein & peptide matrices (.tsv) with %Missing, optional CV_QC.
  • Two versions when MBR matters: MBR-off (primary) and MBR-on (sensitivity).
  • Native score tables & logs + parameters.json (versions, thresholds, IM/RT alignment).
  • QC bundle: FDR curves, CV distributions, missingness heatmap, IM/RT residuals.
  • ID mapping (UniProt ↔ Gene Symbol ↔ Ensembl/Entrez) + field dictionary.
  • Optional: container image digest (for open pipelines) to reproduce runs.

Ion-Mobility DIA Service FAQ: Windows, Libraries, QC Metrics

Q1. What's the practical advantage of Ion-Mobility DIA over conventional DIA?

A: The extra IM (1/K0) dimension reduces co-fragmentation, improving interference control and quant precision—especially in complex matrices—without blowing up cycle time when windows are well planned.

Q2. How many windows should I use for ion-mobility DIA?

A: Start with 4–6 IM slices × 6–8 m/z windows/slice for 30–60 min gradients; 8 × 10–12 for 120 min deep runs. Confirm 8–12×/peak sampling in a pilot.

Q3. Do I always need a project/GPF library?

A: No. Library-free/predicted is sufficient for many research cohorts. Build project/GPF when you need maximum depth or curated panels.

Q4. Should I enable MBR for ion-mobility DIA?

A: Use conservative MBR after alignment QC passes; disclose thresholds and deliver MBR-off/on matrices if calls change materially.

Q5. What QC thresholds should I enforce?

A: Defaults: 1%/1% FDR, QC-pool CV ≤ 20%, missingness ≤ 30%, RT median residual ≤ 30 s (preferably ≤ 15 s), and an IM residual bound aligned to your slice width.

Q6. What causes persistent RT/IM mis-alignment?

A: Column aging, temperature drift, or window congestion. Fix: re-anchor RT with QC-pool, re-bin IM slices, or widen narrow tiles in dense regions.

References:

  1. Meier, Florian, et al. "diaPASEF: parallel accumulation–serial fragmentation combined with data-independent acquisition." Nature Methods 17 (2020): 1229–1236.
  2. Meier, Florian, et al. "Online Parallel Accumulation–Serial Fragmentation (PASEF) with a Novel Trapped Ion Mobility Mass Spectrometer." Molecular & Cellular Proteomics 17 (2018): 2534–2545.
  3. Demichev, Vadim, et al. "DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput." Nature Methods 17 (2020): 41–44.
  4. Gillet, Ludovic C., et al. "Targeted data extraction of the MS/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis." Molecular & Cellular Proteomics 11.6 (2012): O111.016717.
  5. Chen, Shijie, et al. "Establishing Quality Control Metrics for Large-Scale Plasma Proteomic Workflows." ACS Measurement Science Au 4.1 (2024): 32–44.
  6. Reiter, Lukas, et al. "Protein identification false discovery rates for very large proteomics data sets generated by tandem mass spectrometry." Molecular & Cellular Proteomics 8.11 (2009): 2405–2417. DOI: 10.1074/mcp.M900317-MCP200.
* For Research Use Only. Not for use in the treatment or diagnosis of disease.

Online Inquiry

Please submit a detailed description of your project. We will provide you with a customized study plan to meet your requests. You can also send us an email to info@creative-proteomics.org for inquiries.

Online Inquiry

×
LOGO

Specializing in proteomics, Creative Proteomics offers cutting-edge protein analysis services. Our distinctive approach revolves around harnessing the power of DIA technology, enabling us to deliver precise and comprehensive insights that drive advancements in research and industry.

  • USA
  • Tel:
  • Fax:
  • Email:
  • Germany
Copyright © 2025 Creative Proteomics. All rights reserved.